Related Experiment Videos
Social phobia: everyone's disorder?
1Dean Foundation for Health, Research and Education, Madison, Wis. 53717, USA.
The Journal of Clinical Psychiatry
|January 1, 1996
Summary
Serotonin dysfunction is implicated in social phobia, with treatments like SSRIs and beta-blockers showing effectiveness. Further research into serotonin
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Social phobia is a common anxiety disorder.
- Serotonin dysfunction is increasingly recognized as a potential factor in its development.
- Physiological responses like blushing may be linked to serotonin activity.
Purpose of the Study:
- To explore the role of serotonin in the etiology and treatment of social phobia.
- To review pharmacological interventions targeting serotonin pathways for social phobia.
Main Methods:
- Review of existing research on serotonin and social phobia.
- Analysis of drug mechanisms of action in treating social phobia.
Main Results:
- Enhanced cortisol response to fenfluramine (a serotonin agonist) observed in social phobia patients.
- Serotonin selective reuptuptake inhibitors (SSRIs) are effective treatments.
- Other effective medications include benzodiazepines, monoamine oxidase inhibitors (MAOIs), and beta-adrenoceptor blockers.
- Beta-blockers are particularly effective for performance anxiety, a subtype of social phobia.
Conclusions:
- Serotonin plays a significant role in social phobia.
- Pharmacological interventions targeting the serotonin system are crucial for managing social phobia and performance anxiety.